Obesity Surgery

, Volume 28, Issue 10, pp 2998–3006 | Cite as

A Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Acetaminophen on Hospital Length of Stay in Obese Individuals Undergoing Sleeve Gastrectomy

  • Farrell E. Cooke
  • Jon D. Samuels
  • Alfons Pomp
  • Farida Gadalla
  • Xian Wu
  • Cheguevara Afaneh
  • Gregory F. Dakin
  • Peter A. GoldsteinEmail author
Original Contributions



Retrospective studies indicate that acetaminophen iv administration reduces hospital length of stay (LoS) and opiate consumption in patients undergoing bariatric surgery.


This study sought to determine whether using acetaminophen iv in morbidly obese subjects undergoing sleeve gastrectomy decreased LoS and total hospital charges as compared to patients receiving saline placebo.


Single-center university hospital


Using a randomized, double-blind, placebo-controlled design, subjects were assigned to receive either acetaminophen iv (group A) or saline placebo iv (group P). Data were collected between Jan 1 and Dec 31, 2016. Group A received acetaminophen every 6 h for a total of four doses. The first dose was administered following the induction of general anesthesia; group P received saline iv on the same schedule. Anesthetic management and prophylactic antiemetic regimen were standardized in all subjects. Postoperative pain management consisted of hydromorphone via patient-controlled infusion pump. Primary outcomes include hospital LoS and associated hospital costs. Secondary outcomes include patient satisfaction and postoperative nausea and pain scores.


Subject demographics (n = 127) and intraoperative management were similar in the two groups. Across all subjects, median hospital LoS in group A (n = 63) was 1.87 vs. 1.97 days in group P (n = 64) (p = 0.03, Wilcoxon rank-sum test). Postoperatively, daily quality-of-recovery (QoR-15) scores, narcotic consumption, and the use of rescue antiemetics were not significantly different between groups. Median hospital costs were as follows: group A, $12,885 vs. group P, $12,977 (n = 64).


Acetaminophen iv may reduce hospital LoS in subjects undergoing sleeve gastrectomy.


Randomized controlled trial RCT Prospective Placebo Double blind Acetaminophen Obesity Surgery 



This work would not have been possible without the excellent collaboration between the Departments of Anesthesiology and Surgery. The authors wish to expressly thank the many faculty, residents, nurse anesthetists, and research aides in both the Department of Anesthesiology and Surgery for their cooperation and assistance during the course of this study. We also wish to thank Paul Christos, Dr. P.H, M.S., for constructive comments and suggestions on the manuscript.

Author Contributions

Study concept/design (JDS, AP, PAG), data acquisition (FEC, JDS, AP, FG, CA, GFD, PAG), data analysis (FEC, XW, PAG), interpretation of data (FEC, AP, FG, XW, CA, PAG), manuscript preparation (FEC, PAG), manuscript revision/editing (FEC, JDS, AP, FG, XW, CA, GFD, PAG), approval of submitted manuscript (FEC, JDS, AP, FG, XW, CA, GFD, PAG), agreement to be accountable for all aspects of the work (FEC, JDS, AP, FG, XW, CA, GFD, PAG).

Funding Information

This work was funded by Mallinckrodt Pharmaceuticals. Ms. Xian Wu, MPH, was partially supported by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (UL1-TR000457-06).

Compliance with Ethical Standards

Conflict of Interest

FEC, JDS, FG, XW, CA, and GFD have no conflicts to declare. AP has served as a speaker for Medtronic, Ethicon, and W.L. Gore & Associates and has received honoraria from those companies. PAG receives additional research support from the United States Department of Defense and the Tri-Institutional Stem Cell Initiative for basic science research in areas unrelated to the work presented here.


  1. 1.
    Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55(2 Suppl):615S–9S.Google Scholar
  2. 2.
    Hruby A, Hu FB. The epidemiology of obesity: a big picture. PharmacoEconomics. 2015;33(7):673–89.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Chang SH, Pollack LM, Colditz GA. Life years lost associated with obesity-related diseases for U.S. Non-smoking adults. PLoS One. 2013;8(6):e66550.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Flegal KM, Graubard BI, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298(17):2028–37.CrossRefPubMedGoogle Scholar
  5. 5.
    Puzziferri N, Roshek 3rd TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149(7):707–15.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.CrossRefPubMedGoogle Scholar
  10. 10.
    Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288(22):2793–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Våge V, Sande VA, Mellgren G, et al. Changes in obesity-related diseases and biochemical variables after laparoscopic sleeve gastrectomy: a two-year follow-up study. BMC Surg. 2014;14:8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    van Rutte PW, Smulders JF, de Zoete JP, et al. Outcome of sleeve gastrectomy as a primary bariatric procedure. Br J Surg. 2014;101(6):661–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Sieber P, Gass M, Kern B, et al. Five-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(2):243–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Ponce J, DeMaria EJ, Nguyen NT, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis. 2016;12(9):1637–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Benevides ML, Oliveira SS, de Aguilar-Nascimento JE. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obes Surg. 2013;23(9):1389–96.CrossRefPubMedGoogle Scholar
  16. 16.
    Afaneh C, Costa R, Pomp A, et al. A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms. Surg Endosc. 2015;29(1):41–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Mendes MN, Monteiro Rde S, Martins FA. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties: a comparative study among three methods. Rev Bras Anestesiol. 2009;59(5):570–6.PubMedGoogle Scholar
  18. 18.
    Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113.CrossRefPubMedGoogle Scholar
  19. 19.
    Eberhart LH, Mauch M, Morin AM, et al. Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia. 2002;57(10):1022–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Pan PH, Lee SC, Harris LC. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesth Analg. 2008;107(2):429–38.CrossRefPubMedGoogle Scholar
  21. 21.
    Habib AS, Chen YT, Taguchi A, et al. Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis. Curr Med Res Opin. 2006;22(6):1093–9.CrossRefPubMedGoogle Scholar
  22. 22.
    DiIorio TM, Sharkey PF, Hewitt AM, et al. Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting? Clin Orthop Relat Res. 2010;468(9):2405–9.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Pizzi LT, Toner R, Foley K, et al. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy. 2012;32(6):502–14.CrossRefPubMedGoogle Scholar
  24. 24.
    Dzwonczyk R, Weaver TE, Puente EG, et al. Postoperative nausea and vomiting prophylaxis from an economic point of view. Am J Ther. 2012;19(1):11–5.CrossRefPubMedGoogle Scholar
  25. 25.
    De Oliveira Jr GS, Castro-Alves LJ, RJ MC. Single-dose systemic acetaminophen to prevent postoperative pain: a meta-analysis of randomized controlled trials. Clin J Pain. 2015;31(1):86–93.CrossRefPubMedGoogle Scholar
  26. 26.
    Apfel CC, Turan A, Souza K, et al. Intravenous acetaminophen reduces postoperative nausea and vomiting: a systematic review and meta-analysis. Pain. 2013;154(5):677–89.CrossRefPubMedGoogle Scholar
  27. 27.
    Song K, Melroy MJ, Whipple OC. Optimizing multimodal analgesia with intravenous acetaminophen and opioids in postoperative bariatric patients. Pharmacotherapy. 2014;34(Suppl 1):14S–21S.CrossRefPubMedGoogle Scholar
  28. 28.
    Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharmacy. 2009;66(7):642–8.CrossRefGoogle Scholar
  29. 29.
    Ogunnaike BO, Jones SB, Jones DB, et al. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002;95(6):1793–805.CrossRefPubMedGoogle Scholar
  30. 30.
    Chang AK, Bijur PE, Meyer RH, et al. Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial. Ann Emerg Med. 2006;48(2):164–72.CrossRefPubMedGoogle Scholar
  31. 31.
    Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013;118(6):1332–40.CrossRefPubMedGoogle Scholar
  32. 32.
    Lange M, Kia M. Efficacy of IV acetaminophen in laparoscopic roux-En-Y gastric bypass surgery patients. Surg Obes Relat Dis. 2016;12:S60.CrossRefGoogle Scholar
  33. 33.
    Atef A, Fawaz AA. Intravenous paracetamol is highly effective in pain treatment after tonsillectomy in adults. Eur Arch Otorhinolaryngol. 2008;265(3):351–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Jokela R, Ahonen J, Seitsonen E, et al. The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharmacol Ther. 2010;87(6):672–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Wang S, Saha R, Shah N, et al. Effect of intravenous acetaminophen on postoperative opioid use in bariatric surgery patients. P & T. 2015;40(12):847–50.Google Scholar
  36. 36.
    Khorgami Z, Aminian A, Shoar S, et al. Cost of bariatric surgery and factors associated with increased cost: an analysis of national inpatient sample. Surg Obes Relat Dis. 2017;13:1284–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Shaffer EE, Pham A, Woldman RL, et al. Estimating the effect of intravenous acetaminophen for postoperative pain management on length of stay and inpatient hospital costs. Adv Ther. 2017;33(12):2211–28.CrossRefPubMedGoogle Scholar
  38. 38.
    El Chaar M, Stoltzfus J, Claros L, et al. IV acetaminophen results in lower hospital costs and emergency room visits following bariatric surgery: a double-blind, prospective, randomized trial in a single accredited bariatric center. J Gastrointest Surg. 2016;20(4):715–24.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Farrell E. Cooke
    • 1
  • Jon D. Samuels
    • 1
  • Alfons Pomp
    • 2
  • Farida Gadalla
    • 1
  • Xian Wu
    • 3
  • Cheguevara Afaneh
    • 2
  • Gregory F. Dakin
    • 2
  • Peter A. Goldstein
    • 1
    • 4
    Email author
  1. 1.Department of AnesthesiologyWeill Cornell Medical CollegeNew YorkUSA
  2. 2.Department of SurgeryWeill Cornell Medical CollegeNew YorkUSA
  3. 3.Department of Healthcare Policy and Research (Division of Biostatistics and Epidemiology)Weill Cornell Medical CollegeNew YorkUSA
  4. 4.Department of MedicineWeill Cornell Medical CollegeNew YorkUSA

Personalised recommendations